Home/Filings/4/0001140361-19-000110
4//SEC Filing

ORAN STUART I 4

Accession 0001140361-19-000110

CIK 0001476651other

Filed

Jan 1, 7:00 PM ET

Accepted

Jan 2, 4:35 PM ET

Size

24.3 KB

Accession

0001140361-19-000110

Insider Transaction Report

Form 4
Period: 2019-01-01
ORAN STUART I
DirectorSecretary
Transactions
  • Disposition to Issuer

    Common Stock Warrants (right to buy)

    2019-01-0110,5000 total(indirect: By Trust)
    Exp: 2019-11-12Class A Common Stock (10,500 underlying)
  • Disposition to Issuer

    Option to Purchase

    2019-01-0110,0000 total
    Exercise: $23.97Exp: 2025-02-10Class A Common Stock (10,000 underlying)
  • Disposition to Issuer

    Class A Common Stock, par value $.001 per share

    2019-01-013150 total(indirect: By LLC)
  • Disposition to Issuer

    Common Stock Warrants (right to buy)

    2019-01-0115,7500 total(indirect: By Trust)
    Exp: 2019-11-12Class A Common Stock (15,750 underlying)
  • Disposition to Issuer

    Class A Common Stock, par value $.001 per share

    2019-01-018,8040 total
  • Disposition to Issuer

    Common Stock Warrants (right to buy)

    2019-01-01124,9050 total
    Exp: 2019-11-12Class A Common Stock (124,905 underlying)
  • Disposition to Issuer

    Option to Purchase

    2019-01-0141,2390 total
    Exercise: $21.00Exp: 2021-01-10Class A Common Stock (41,239 underlying)
  • Disposition to Issuer

    Option to Purchase

    2019-01-0180,0000 total
    Exercise: $19.75Exp: 2023-12-23Class A Common Stock (80,000 underlying)
Footnotes (9)
  • [F1]Disposed of pursuant to the Agreement and Plan of Merger (the "Merger Agreement") between the Issuer and Synovus Financial Corp. ("Synovus") in exchange for 8,955 shares of common stock, par value $1.00 per share, of Synovus having a market value of $31.99 per share as of the close of trading on December 31, 2018, the last trading day prior to the effective time of the merger.
  • [F2]Disposed of pursuant to the Merger Agreement in exchange for 332 shares of common stock, par value $1.00 per share, of Synovus having a market value of $31.99 per share as of the close of trading on December 31, 2018, the last trading day prior to the effective time of the merger.
  • [F3]This option, which is fully vested and became exercisable on January 25, 2013, was converted into an option to purchase 43,507 shares of Synovus common stock for $19.91 per share.
  • [F4]This option, which provided for vesting immediately upon issuance on December 23, 2013 and became exercisable in equal installments 6, 18 and 30 months following the Issuer's initial public offering, was converted into an option to purchase 84,400 shares of Synovus common stock for $18.72 per share.
  • [F5]This option, which provided for vesting on each of April 1, 2015, July 1, 2015, October 1, 2015 and January 1, 2016 in equal installments, was converted into an option to purchase 10,550 shares of Synovus common stock for $22.72 per share.
  • [F6]This option, which provided for vesting on each of April 1, 2016, July 1, 2016, October 1, 2016 and January 1, 2017 in equal installments, was converted into an option to purchase 10,550 shares of Synovus common stock for $28.42 per share.
  • [F7]These warrants, which provided that they became exercisable in three substantially equal portions on each of the 6-month, 18-month and 30-month anniversaries of the consummation of the Issuer's initial public offering, were converted into warrants to purchase 131,774 shares of Synovus common stock for $22.98 per share, $24.82 per share and $26.81 per share for the portion of the warrants that became exercisable on each of the 6-month, 18-month and 30-month anniversaries of the consummation of the Issuer's initial public offering, respectively.
  • [F8]These warrants, which provided that they became exercisable in three substantially equal portions on each of the 6-month, 18-month and 30-month anniversaries of the consummation of the Issuer's initial public offering, were converted into warrants to purchase 11,077 shares of Synovus common stock for $22.98 per share, $24.82 per share and $26.81 per share for the portion of the warrants that became exercisable on each of the 6-month, 18-month and 30-month anniversaries of the consummation of the Issuer's initial public offering, respectively. The reporting person disclaims beneficial ownership of the warrants held by this trust.
  • [F9]These warrants, which provided that they became exercisable in three substantially equal portions on each of the 6-month, 18-month and 30-month anniversaries of the consummation of the Issuer's initial public offering, were converted into warrants to purchase 16,616 shares of Synovus common stock for $22.98 per share, $24.82 per share and $26.81 per share for the portion of the warrants that became exercisable on each of the 6-month, 18-month and 30-month anniversaries of the consummation of the Issuer's initial public offering, respectively. The reporting person disclaims beneficial ownership of the warrants held by this trust.

Issuer

FCB FINANCIAL HOLDINGS, INC.

CIK 0001476651

Entity typeother

Related Parties

1
  • filerCIK 0001017974

Filing Metadata

Form type
4
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 4:35 PM ET
Size
24.3 KB